StockData
ImageneBio, Inc. logo

ImageneBio, Inc. (IMA) stock

IMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30
$3.81−0.09 (-2.31%)

Close on Nov 18, 2026Market cap $43.25MP/E –Yield –

ImageneBio revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

ImageneBio's revenue for the twelve months ending Dec 31, 2025 was $800.00K, down 77.1% year over year. For fiscal 2025 it was $800.00K, down 77.1% from the year before. The highest annual figure on record is $30.99M in fiscal 2021.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$800.00K-77.1%
FY2024Dec 31, 2024$3.50M-61.8%
FY2023Dec 31, 2023$9.16M-41.3%
FY2022Dec 31, 2022$15.62M-49.6%
FY2021Dec 31, 2021$30.99M+237.0%
FY2020Dec 31, 2020$9.19M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025$0–
Q3 FY2025Sep 30, 2025$0-100.0%
Q2 FY2025Jun 30, 2025$0-100.0%
Q1 FY2025Mar 31, 2025$800.00K-32.5%
Q4 FY2024Dec 31, 2024$0-100.0%
Q3 FY2024Sep 30, 2024$3.50M-34.1%
Q4 FY2023Dec 31, 2023$659.00K-87.9%
Q3 FY2023Sep 30, 2023$1.19M-81.5%
Q2 FY2023Jun 30, 2023$2.00M+424.6%
Q1 FY2023Mar 31, 2023$5.31M+57.0%
Q4 FY2022Dec 31, 2022$5.45M-73.0%
Q3 FY2022Sep 30, 2022$6.40M+70.9%
Q2 FY2022Jun 30, 2022$382.00K-89.2%
Q1 FY2022Mar 31, 2022$3.38M-2.6%
Q4 FY2021Dec 31, 2021$20.22M+31003.1%
Q3 FY2021Sep 30, 2021$3.75M+32.4%
Q2 FY2021Jun 30, 2021$3.55M+15.5%
Q1 FY2021Mar 31, 2021$3.47M+7.7%
Q4 FY2020Dec 31, 2020$65.00K–
Q3 FY2020Sep 30, 2020$2.83M–
Q2 FY2020Jun 30, 2020$3.07M–
Q1 FY2020Mar 31, 2020$3.23M–

More ImageneBio figures

See a number that looks wrong?